Onward develops an Implantable Neuro-stimulation System (INS) with real-time motion feedback and uses training tools.
Onward has raised $47.8M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in April 2026.
Onward's investors include Invest-NL, Ottobock, European Innovation Council, Inkef, EQT Life Sciences.
Onward is headquartered in Eindhoven, The Netherlands.
Onward develops an Implantable Neuro-stimulation System (INS) with real-time motion feedback and uses training tools.
Onward is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Onward — Funding & Investors." VCBacked, April 16, 2026, https://www.vcbacked.co/company/onward-eindhoven. Accessed July 19, 2026.
VCBacked. (2026). Onward — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/onward-eindhoven
{{cite web |title=Onward — Funding & Investors |url=https://www.vcbacked.co/company/onward-eindhoven |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated